Thomson Reuters logo


Healthcare Solutions

 
About UsContact UsPress RoomCareers
Nurses
Physicians
Pharmacists
Managed Care
Clinical Workflow
Academics
Environmental Health and Safety
Clinical Download Library
Subscriber Login
DRUGDEX® System Editorial Updates

Impartial, evidence-based resources to help answer your drug information needs

The following information is intended for use by competent health care professionals and academia. You assume full responsibility for ensuring the appropriate use and reliance upon this information.

2004 FDA APPROVALS

EARLY RELEASE
  • Abacavir/Lamivudine - New Monograph (updated September, 2004)
  • Acamprosate - Update Monograph - New FDA Approval (updated September, 2004)
  • Alvimopan - New Monograph (updated September, 2004)
  • Asparaginase - Update Dosage, Adult (usual) in DrugPoints (updated October, 2004)
  • Cilansetron - New Monograph (updated November, 2004)
  • Clofarabine - Updated Monograph - New FDA Approval (updated December, 2004)
  • Conivaptan - New Monoagraph (updated September, 2004)
  • Darifenacin - Updated Monograph - New FDA Approval (updated December, 2004)
  • Duloxetine - Updated Monograph - New FDA Approval (updated September, 2004)
  • Emtricitabine/tenofovir - New Monograph (updated September, 2004)
  • Eptifibatide - Update Dosage in Renal Failure (updated October, 2004)
  • Erlotinib - Updated Monograph - New FDA Approval (updated December, 2004)
  • Eszopiclone - Updated Monograph - New FDA Approval (updated December, 2004)
  • Ezetimibe/simvastatin - New Monograph (updated September, 2004)
  • Gadobenate Dimeglumine - Updated Monograph - New FDA Approval (updated December, 2004)
  • Gadofosveset - New Monograph (December, 2004)
  • Iloprost - Updated Monograph - New FDA Approval (updated December, 2004)
  • Infliximab - New FDA Labeled Indication - Active ankylosing spondylitis (updated December, 2004)
  • Lanthanum Carbonate - Updated Monograph - New FDA Approval (updated December, 2004)
  • Lutropin Alfa - New Monograph (updated November, 2004)
  • Natalizumab - Updated Monograph - New FDA Approval (updated December, 2004)
  • Palifermin - New Monograph - New FDA Approval (updated December, 2004)
  • Pegaptanib - New Monograph - New FDA Approval (updated December, 2004)
  • Pentetate Calcium Trisodium - New Monograph (updated September, 2004)
  • Pentetate Zinc Trisodium - New Monograph (updated September, 2004)
  • Pixantrone - New Monograph (December, 2004)
  • Posaconazole - New Monograph (December, 2004)
  • Rofecoxib- Updated Monograph - Market Withdrawal (updated September, 2004)
  • Solifenacin - Updated Monograph - New FDA Approval (updated December, 2004)
  • Technetium (99M TC) Fanolesomab - New Monograph (November, 2004)
  • Tegaserod - New FDA Labeled Indication - Chronic idiopathic constipation (updated September, 2004)
  • Vapreotide - New Monograph (updated November, 2004)
  • Voriconazole - New FDA Labeled Indication - Candidemia in nonneutropenic patients and Candida infections (updated December, 2004)
  • Ziconotide - Updated Monograph - New FDA Approval (updated December, 2004)
  • Ziprasidone- New FDA Labeled Indication - Bipolar disorder, manic episode (updated September, 2004)

Home   |   Products   |   Solutions   |   Support   |   Partners   |   About Us   |   Contact Us   |   Press Room   |   Careers
Copyright Notices   |   Terms of Use   |   Privacy Statement   |   How to Cite